148 related articles for article (PubMed ID: 20822327)
1. Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth.
Bastek JA; Brown AG; Anton L; Srinivas SK; D'addio A; Elovitz MA
J Matern Fetal Neonatal Med; 2011 Apr; 24(4):600-5. PubMed ID: 20822327
[TBL] [Abstract][Full Text] [Related]
2. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
Smith GC; Crossley JA; Aitken DA; Jenkins N; Lyall F; Cameron AD; Connor JM; Dobbie R
Obstet Gynecol; 2007 Jun; 109(6):1316-24. PubMed ID: 17540803
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
Asvold BO; Eskild A; Vatten LJ
Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
[TBL] [Abstract][Full Text] [Related]
4. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
[TBL] [Abstract][Full Text] [Related]
5. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
Lenderink T; Heeschen C; Fichtlscherer S; Dimmeler S; Hamm CW; Zeiher AM; Simoons ML; Boersma E;
J Am Coll Cardiol; 2006 Jan; 47(2):307-11. PubMed ID: 16412852
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of placental growth factor in patients with acute chest pain.
Heeschen C; Dimmeler S; Fichtlscherer S; Hamm CW; Berger J; Simoons ML; Zeiher AM;
JAMA; 2004 Jan; 291(4):435-41. PubMed ID: 14747500
[TBL] [Abstract][Full Text] [Related]
7. Fetal sex specific differences in human placentation: a prospective cohort study.
Brown ZA; Schalekamp-Timmermans S; Tiemeier HW; Hofman A; Jaddoe VW; Steegers EA
Placenta; 2014 Jun; 35(6):359-64. PubMed ID: 24720894
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
9. Examining the correlation between placental and serum placenta growth factor in preeclampsia.
Weed S; Bastek JA; Anton L; Elovitz MA; Parry S; Srinivas SK
Am J Obstet Gynecol; 2012 Aug; 207(2):140.e1-6. PubMed ID: 22704767
[TBL] [Abstract][Full Text] [Related]
10. The soluble receptor for advanced glycation end products can prospectively identify patients at greatest risk for preterm birth.
Bastek JA; Brown AG; Foreman MN; McShea MA; Anglim LM; Adamczak JE; Elovitz MA
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1762-8. PubMed ID: 22339587
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion.
Triunfo S; Lobmaier S; Parra-Saavedra M; Crovetto F; Peguero A; Nadal A; Gratacos E; Figueras F
Placenta; 2014 Jun; 35(6):398-403. PubMed ID: 24746262
[TBL] [Abstract][Full Text] [Related]
12. Placental growth factor in the first trimester: relationship with maternal factors and placental Doppler studies.
Kasdaglis T; Aberdeen G; Turan O; Kopelman J; Atlas R; Jenkins C; Blitzer M; Harman C; Baschat AA
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):280-5. PubMed ID: 20052659
[TBL] [Abstract][Full Text] [Related]
13. The relationship of circulating proteins in early pregnancy with preterm birth.
Lynch AM; Wagner BD; Deterding RR; Giclas PC; Gibbs RS; Janoff EN; Holers VM; Santoro NF
Am J Obstet Gynecol; 2016 Apr; 214(4):517.e1-517.e8. PubMed ID: 26576488
[TBL] [Abstract][Full Text] [Related]
14. Predictors of preterm birth in patients with mild systemic lupus erythematosus.
Clowse ME; Wallace DJ; Weisman M; James A; Criscione-Schreiber LG; Pisetsky DS
Ann Rheum Dis; 2013 Sep; 72(9):1536-9. PubMed ID: 23361085
[TBL] [Abstract][Full Text] [Related]
15. Risk of placental dysfunction disorders after prior miscarriages: a population-based study.
Gunnarsdottir J; Stephansson O; Cnattingius S; Akerud H; Wikström AK
Am J Obstet Gynecol; 2014 Jul; 211(1):34.e1-8. PubMed ID: 24495667
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.
Thadhani R; Ecker JL; Mutter WP; Wolf M; Smirnakis KV; Sukhatme VP; Levine RJ; Karumanchi SA
Hypertension; 2004 May; 43(5):988-92. PubMed ID: 15023932
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
18. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Tsiakkas A; Duvdevani N; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 May; 45(5):591-8. PubMed ID: 25653039
[TBL] [Abstract][Full Text] [Related]
19. Elevated C-reactive protein and complement C3 levels are associated with preterm birth: a nested case-control study in Chinese women.
Huang S; Tian J; Liu C; Long Y; Cao D; Wei L; Zhu X; Tang R; Liu W; Zeng D; Li M; Yang X; Mo Z
BMC Pregnancy Childbirth; 2020 Feb; 20(1):131. PubMed ID: 32106828
[TBL] [Abstract][Full Text] [Related]
20. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
